Cargando…
Expression of Irisin/FNDC5 in Cancer Cells and Stromal Fibroblasts of Non-Small Cell Lung Cancer
Background: Recent in vitro studies have indicated that irisin inhibits proliferation, migration and epithelial-mesenchymal transition. Irisin expression has not been studied in tumour tissues of non-small cell lung cancer (NSCLC) patients yet. The aim of the study was to determine the irisin expres...
Autores principales: | Nowinska, Katarzyna, Jablonska, Karolina, Pawelczyk, Konrad, Piotrowska, Aleksandra, Partynska, Aleksandra, Gomulkiewicz, Agnieszka, Ciesielska, Urszula, Katnik, Ewa, Grzegrzolka, Jedrzej, Glatzel-Plucinska, Natalia, Ratajczak-Wielgomas, Katarzyna, Podhorska-Okolow, Marzenna, Dziegiel, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826442/ https://www.ncbi.nlm.nih.gov/pubmed/31614634 http://dx.doi.org/10.3390/cancers11101538 |
Ejemplares similares
-
Association of Irisin/FNDC5 with ERRα and PGC-1α Expression in NSCLC
por: Nowińska, Katarzyna, et al.
Publicado: (2022) -
Prognostic Significance of Stromal Periostin Expression in Non-Small Cell Lung Cancer
por: Ratajczak-Wielgomas, Katarzyna, et al.
Publicado: (2020) -
The Role of Irisin/FNDC5 Expression and Its Serum Level in Breast Cancer
por: Cebulski, Kamil, et al.
Publicado: (2023) -
Role of PD-L1 Expression in Non-Small Cell Lung Cancer and Their Prognostic Significance according to Clinicopathological Factors and Diagnostic Markers
por: Pawelczyk, Konrad, et al.
Publicado: (2019) -
Expression of Zyxin in Non-Small Cell Lung Cancer—A Preliminary Study
por: Partynska, Aleksandra, et al.
Publicado: (2022)